Michael May Guest

Michael May

Michael May is President and CEO of the Centre for Commercialization of Regenerative Medicine (CCRM), a Canadian, not-for-profit that develops technologies, launches new companies and catalyzes investment in the field of regenerative medicine, including cell and gene therapy. Prior to CCRM, Michael was the President, and co-founder, of Rimon Therapeutics Ltd., a Toronto-based tissue engineering company developing novel medical polymers that possess drug-like activity.

LinkedIn

Appears in 1 Episode

Michael May | Centre for Commercialization of Regenerative Medicine
S2 #14

Michael May | Centre for Commercialization of Regenerative Medicine

July 16th 2024 - From the archives, our guest this week is Michael May, President and CEO of the Centre for Commercialization of Regenerative Medicine. Michael is someone I've had the pleasure of meeting on a number of occasions and he's one of those people you just know you're going to like. He's focused, incredibly generous with his time, and one of the true national leaders in Canada's life sciences community. Michael's story is similar to many of the guests we've had on our show in that it's not a linear path nor was it planned. You'll hear that his success is based on hard work, being open to opportunity when it presents itself, and sometimes learning life lessons from family pets. CCRM: ccrm.caGet Your Tickets to The NGBI Summit: nextgreatbigideas.comLab Occupier: laboccupier.com